The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Finasteride API Market Research Report 2025
Synopsis
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
The global Finasteride API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Finasteride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Finasteride API.
Report Scope
The Finasteride API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Finasteride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMRI
Mylan
Accord Pharmaceuticals
Sterling Spa
DEAFARMA
Gadea Grupo Farmacéutico, S.L.U.
Hetero
Dr.Reddys Laboratories
Pharmaffiliates
Cipla
Henan Topfond
Khonsu International
Aurobindo Pharma
Segment by Type
Abrove 99% Purity
99% Purity
Under 99% Purity
Segment by Application
Pharmaceutical Industry
Research Organization
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Finasteride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Finasteride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Finasteride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
The global Finasteride API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Finasteride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Finasteride API.
Report Scope
The Finasteride API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Finasteride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMRI
Mylan
Accord Pharmaceuticals
Sterling Spa
DEAFARMA
Gadea Grupo Farmacéutico, S.L.U.
Hetero
Dr.Reddys Laboratories
Pharmaffiliates
Cipla
Henan Topfond
Khonsu International
Aurobindo Pharma
Segment by Type
Abrove 99% Purity
99% Purity
Under 99% Purity
Segment by Application
Pharmaceutical Industry
Research Organization
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Finasteride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Finasteride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Finasteride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Finasteride API Market Overview
1.1 Product Definition
1.2 Finasteride API Segment by Type
1.2.1 Global Finasteride API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Abrove 99% Purity
1.2.3 99% Purity
1.2.4 Under 99% Purity
1.3 Finasteride API Segment by Application
1.3.1 Global Finasteride API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Research Organization
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Finasteride API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Finasteride API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Finasteride API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Finasteride API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Finasteride API Production Market Share by Manufacturers (2019-2024)
2.2 Global Finasteride API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Finasteride API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Finasteride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Finasteride API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Finasteride API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Finasteride API, Product Offered and Application
2.8 Global Key Manufacturers of Finasteride API, Date of Enter into This Industry
2.9 Finasteride API Market Competitive Situation and Trends
2.9.1 Finasteride API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Finasteride API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Finasteride API Production by Region
3.1 Global Finasteride API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Finasteride API Production Value by Region (2019-2030)
3.2.1 Global Finasteride API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Finasteride API by Region (2025-2030)
3.3 Global Finasteride API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Finasteride API Production by Region (2019-2030)
3.4.1 Global Finasteride API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Finasteride API by Region (2025-2030)
3.5 Global Finasteride API Market Price Analysis by Region (2019-2024)
3.6 Global Finasteride API Production and Value, Year-over-Year Growth
3.6.1 North America Finasteride API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Finasteride API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Finasteride API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Finasteride API Production Value Estimates and Forecasts (2019-2030)
4 Finasteride API Consumption by Region
4.1 Global Finasteride API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Finasteride API Consumption by Region (2019-2030)
4.2.1 Global Finasteride API Consumption by Region (2019-2024)
4.2.2 Global Finasteride API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Finasteride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Finasteride API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Finasteride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Finasteride API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Finasteride API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Finasteride API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Finasteride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Finasteride API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Finasteride API Production by Type (2019-2030)
5.1.1 Global Finasteride API Production by Type (2019-2024)
5.1.2 Global Finasteride API Production by Type (2025-2030)
5.1.3 Global Finasteride API Production Market Share by Type (2019-2030)
5.2 Global Finasteride API Production Value by Type (2019-2030)
5.2.1 Global Finasteride API Production Value by Type (2019-2024)
5.2.2 Global Finasteride API Production Value by Type (2025-2030)
5.2.3 Global Finasteride API Production Value Market Share by Type (2019-2030)
5.3 Global Finasteride API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Finasteride API Production by Application (2019-2030)
6.1.1 Global Finasteride API Production by Application (2019-2024)
6.1.2 Global Finasteride API Production by Application (2025-2030)
6.1.3 Global Finasteride API Production Market Share by Application (2019-2030)
6.2 Global Finasteride API Production Value by Application (2019-2030)
6.2.1 Global Finasteride API Production Value by Application (2019-2024)
6.2.2 Global Finasteride API Production Value by Application (2025-2030)
6.2.3 Global Finasteride API Production Value Market Share by Application (2019-2030)
6.3 Global Finasteride API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 AMRI
7.1.1 AMRI Finasteride API Corporation Information
7.1.2 AMRI Finasteride API Product Portfolio
7.1.3 AMRI Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 AMRI Main Business and Markets Served
7.1.5 AMRI Recent Developments/Updates
7.2 Mylan
7.2.1 Mylan Finasteride API Corporation Information
7.2.2 Mylan Finasteride API Product Portfolio
7.2.3 Mylan Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Mylan Main Business and Markets Served
7.2.5 Mylan Recent Developments/Updates
7.3 Accord Pharmaceuticals
7.3.1 Accord Pharmaceuticals Finasteride API Corporation Information
7.3.2 Accord Pharmaceuticals Finasteride API Product Portfolio
7.3.3 Accord Pharmaceuticals Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Accord Pharmaceuticals Main Business and Markets Served
7.3.5 Accord Pharmaceuticals Recent Developments/Updates
7.4 Sterling Spa
7.4.1 Sterling Spa Finasteride API Corporation Information
7.4.2 Sterling Spa Finasteride API Product Portfolio
7.4.3 Sterling Spa Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Sterling Spa Main Business and Markets Served
7.4.5 Sterling Spa Recent Developments/Updates
7.5 DEAFARMA
7.5.1 DEAFARMA Finasteride API Corporation Information
7.5.2 DEAFARMA Finasteride API Product Portfolio
7.5.3 DEAFARMA Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 DEAFARMA Main Business and Markets Served
7.5.5 DEAFARMA Recent Developments/Updates
7.6 Gadea Grupo Farmacéutico, S.L.U.
7.6.1 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Corporation Information
7.6.2 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Product Portfolio
7.6.3 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Gadea Grupo Farmacéutico, S.L.U. Main Business and Markets Served
7.6.5 Gadea Grupo Farmacéutico, S.L.U. Recent Developments/Updates
7.7 Hetero
7.7.1 Hetero Finasteride API Corporation Information
7.7.2 Hetero Finasteride API Product Portfolio
7.7.3 Hetero Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Hetero Main Business and Markets Served
7.7.5 Hetero Recent Developments/Updates
7.8 Dr.Reddys Laboratories
7.8.1 Dr.Reddys Laboratories Finasteride API Corporation Information
7.8.2 Dr.Reddys Laboratories Finasteride API Product Portfolio
7.8.3 Dr.Reddys Laboratories Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Dr.Reddys Laboratories Main Business and Markets Served
7.7.5 Dr.Reddys Laboratories Recent Developments/Updates
7.9 Pharmaffiliates
7.9.1 Pharmaffiliates Finasteride API Corporation Information
7.9.2 Pharmaffiliates Finasteride API Product Portfolio
7.9.3 Pharmaffiliates Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Pharmaffiliates Main Business and Markets Served
7.9.5 Pharmaffiliates Recent Developments/Updates
7.10 Cipla
7.10.1 Cipla Finasteride API Corporation Information
7.10.2 Cipla Finasteride API Product Portfolio
7.10.3 Cipla Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Cipla Main Business and Markets Served
7.10.5 Cipla Recent Developments/Updates
7.11 Henan Topfond
7.11.1 Henan Topfond Finasteride API Corporation Information
7.11.2 Henan Topfond Finasteride API Product Portfolio
7.11.3 Henan Topfond Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Henan Topfond Main Business and Markets Served
7.11.5 Henan Topfond Recent Developments/Updates
7.12 Khonsu International
7.12.1 Khonsu International Finasteride API Corporation Information
7.12.2 Khonsu International Finasteride API Product Portfolio
7.12.3 Khonsu International Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Khonsu International Main Business and Markets Served
7.12.5 Khonsu International Recent Developments/Updates
7.13 Aurobindo Pharma
7.13.1 Aurobindo Pharma Finasteride API Corporation Information
7.13.2 Aurobindo Pharma Finasteride API Product Portfolio
7.13.3 Aurobindo Pharma Finasteride API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Aurobindo Pharma Main Business and Markets Served
7.13.5 Aurobindo Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Finasteride API Industry Chain Analysis
8.2 Finasteride API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Finasteride API Production Mode & Process
8.4 Finasteride API Sales and Marketing
8.4.1 Finasteride API Sales Channels
8.4.2 Finasteride API Distributors
8.5 Finasteride API Customers
9 Finasteride API Market Dynamics
9.1 Finasteride API Industry Trends
9.2 Finasteride API Market Drivers
9.3 Finasteride API Market Challenges
9.4 Finasteride API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
